Andrew Carr

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Andrew Carr, Katherine Samaras, Gilbert R. Kaufmann et al. · The Lancet · 1999 · 1.5K citations

Medicine, Endocrinology, Infectious Diseases +16

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome

Andrew Carr, J. Philip Miller, Matthew Law et al. · AIDS · 2000 · 641 citations

Medicine, Pharmacotherapy, Clinical Nutrition +16

A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease

Sven A. Danner, Andrew Carr, John M. Leonard et al. · New England Journal of Medicine · 1995 · 573 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission

Tuofu Zhu, Na Wang, Andrew Carr et al. · Journal of Virology · 1996 · 441 citations · Full text

Life Sciences, Genetics, Infectious Diseases +13

Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy

Judith S. Currier, Jens Lundgren, Andrew Carr et al. · Circulation · 2008 · 361 citations · Full text

Public Health, Cardiology, Infectious Diseases +17